CBC Group Overview
- Investor Type
-
PE/Buyout
- Status
-
Active
- Professionals
-
13
- Investments
-
56
- Portfolio
-
26
- Exits
-
13
CBC Group General Information
Company Description
Founded in 2014, CBC Group is a private equity firm based in Singapore. The firm seeks to invest in the pharmaceutical, biotechnology, medical technology, and healthcare services sectors.
Business Details
Investor Status
Primary Investor Type
Other Investor Types
Corporate Office
- 88 Market Street
- Number 46-04/05, CapitaSpring
- Singapore, 048948
- Singapore
CBC Group Investments (56)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| UCB (Mature Business in China) | 26-Aug-2024 | 0000000000 | 00000 | Buildings and Property | 000 00 | |
| UCB (Neurology and Allergy Business) | 26-Aug-2024 | 0000000000 | 00000 | Pharmaceuticals | Generating Revenue | 000 00 |
| Celltrion (14 Branded Products and Marketing Authorization Holder Rights) | 28-Jun-2024 | 0000000000 | Buildings and Property | Generating Revenue | 000 00 | |
| Takeda Pharmaceutical Company (Asia Pacific Primary Care Business Rights) | 01-Jan-2024 | 0000000000 | 00000 | Buildings and Property | ||
| Hasten Biopharma | 20-Apr-2023 | PE Growth/Expansion | 00000 | Drug Discovery | Generating Revenue | 000 00 |
CBC Group Exits (13)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| YS Biopharma | 15-Mar-2023 | 0000000 0000 | 00000 |
| FiscalNote Holdings | 01-Aug-2022 | 0000000 0000 | 00000 |
| Clarus Therapeutics | 09-Sep-2021 | 0000000 0000 | 000.00 |
| CMAB | 07-May-2021 | 000000000000 | 000.00 |
| Everest Medicines | 09-Oct-2020 | IPO | 00000 |
CBC Group Fund Performance
| Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
|---|
CBC Group Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
CBC Group Management, Team & Partners (26)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| Hans Kang | Senior Managing Director, Head of Real Assets and Chief Executive Officer of Healthcare Infrastructure Platform | Shanghai, China | |||
| Wei Fu | Founder & Chief Executive Officer | 00 | 0 | 0 | Singapore, Singapore |
| Todd Slattery | Senior Managing Director and Group Chief Operating Officer | New York, NY | |||
| Sean Lu | Senior Managing Director, Private Equity and Head of MedTech and Services | Shanghai, China | |||
| Annie Lee | Senior Managing Director, Private Equity and Head of Pharma | Shanghai, China |
CBC Group FAQs
-
What is CBC Group?
Founded in 2014, CBC Group is a private equity firm based in Singapore.
-
When was CBC Group founded?
CBC Group was founded in 2014.
-
Who is the founder of CBC Group?
Wei Fu is the founder of CBC Group.
-
Who is the CEO of CBC Group?
-
Where is CBC Group headquartered?
CBC Group is headquartered in Singapore, Singapore.
-
What is CBC Group's total asset value?
CBC Group has around 00.00 in total assets under management.
-
How many investments has CBC Group made?
CBC Group has made 56 investments.
-
What has CBC Group invested in?
CBC Group has made numerous investments in companies like UCB (Mature Business in China), UCB (Neurology and Allergy Business), and Celltrion (14 Branded Products and Marketing Authorization Holder Rights) within the Buildings and Property and Pharmaceuticals industries.
-
What has CBC Group invested in recently?
CBC Group's latest investment was on 26-Aug-2024 in UCB (Mature Business in China), a company within the Buildings and Property industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
